437 related articles for article (PubMed ID: 21815745)
1. Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.
Pandey KN
Can J Physiol Pharmacol; 2011 Aug; 89(8):557-73. PubMed ID: 21815745
[TBL] [Abstract][Full Text] [Related]
2. Intracellular trafficking and metabolic turnover of ligand-bound guanylyl cyclase/atrial natriuretic peptide receptor-A into subcellular compartments.
Pandey KN
Mol Cell Biochem; 2002 Jan; 230(1-2):61-72. PubMed ID: 11952097
[TBL] [Abstract][Full Text] [Related]
3. Ligand-Dependent Downregulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Role of miR-128 and miR-195.
Khurana ML; Mani I; Kumar P; Ramasamy C; Pandey KN
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362173
[TBL] [Abstract][Full Text] [Related]
4. Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.
Pandey KN
Physiol Genomics; 2018 Nov; 50(11):913-928. PubMed ID: 30169131
[TBL] [Abstract][Full Text] [Related]
5. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
6. Roles of guanylyl cyclase--a signaling in the cardiovascular system.
Saito Y; Kishimoto I; Nakao K
Can J Physiol Pharmacol; 2011 Aug; 89(8):551-6. PubMed ID: 21671770
[TBL] [Abstract][Full Text] [Related]
7. Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis.
Pandey KN
Front Physiol; 2021; 12():693099. PubMed ID: 34489721
[TBL] [Abstract][Full Text] [Related]
8. Clathrin-dependent internalization, signaling, and metabolic processing of guanylyl cyclase/natriuretic peptide receptor-A.
Somanna NK; Mani I; Tripathi S; Pandey KN
Mol Cell Biochem; 2018 Apr; 441(1-2):135-150. PubMed ID: 28900772
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide.
Goy MF; Oliver PM; Purdy KE; Knowles JW; Fox JE; Mohler PJ; Qian X; Smithies O; Maeda N
Biochem J; 2001 Sep; 358(Pt 2):379-87. PubMed ID: 11513736
[TBL] [Abstract][Full Text] [Related]
10. The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.
Pandey KN
FEBS J; 2011 Jun; 278(11):1792-807. PubMed ID: 21375691
[TBL] [Abstract][Full Text] [Related]
11. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.
Patel JB; Valencik ML; Pritchett AM; Burnett JC; McDonald JA; Redfield MM
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H777-84. PubMed ID: 15778276
[TBL] [Abstract][Full Text] [Related]
12. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases.
Tremblay J; Desjardins R; Hum D; Gutkowska J; Hamet P
Mol Cell Biochem; 2002 Jan; 230(1-2):31-47. PubMed ID: 11952095
[TBL] [Abstract][Full Text] [Related]
13. C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.
Savoie P; de Champlain J; Anand-Srivastava MB
FEBS Lett; 1995 Aug; 370(1-2):6-10. PubMed ID: 7649305
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of internalization and sequestration of guanylyl cyclase/atrial natriuretic peptide receptor-A.
Pandey KN
Can J Physiol Pharmacol; 2001 Aug; 79(8):631-9. PubMed ID: 11558671
[TBL] [Abstract][Full Text] [Related]
15. Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation.
Ma X; Iyer SR; Ma X; Reginauld SH; Chen Y; Pan S; Zheng Y; Moroni DG; Yu Y; Zhang L; Cannone V; Chen HH; Ferrario CM; Sangaralingham SJ; Burnett JC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239899
[TBL] [Abstract][Full Text] [Related]
16. Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.
Kishimoto I; Hamra FK; Garbers DL
Can J Physiol Pharmacol; 2001 Aug; 79(8):715-22. PubMed ID: 11558680
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
18. Ligand-mediated endocytosis and intracellular sequestration of guanylyl cyclase/natriuretic peptide receptors: role of GDAY motif.
Pandey KN
Mol Cell Biochem; 2010 Jan; 334(1-2):81-98. PubMed ID: 19941037
[TBL] [Abstract][Full Text] [Related]
19. Novel enhancers of guanylyl cyclase-A activity acting via allosteric modulation.
Andresen H; Pérez-Ternero C; Robinson J; Dickey DM; Hobbs AJ; Potter LR; Levy FO; Cataliotti A; Moltzau LR
Br J Pharmacol; 2023 Dec; 180(24):3254-3270. PubMed ID: 37522273
[TBL] [Abstract][Full Text] [Related]
20. Internalization and trafficking of guanylyl cyclase/natriuretic peptide receptor-A.
Pandey KN
Peptides; 2005 Jun; 26(6):985-1000. PubMed ID: 15911067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
